A DEXAMETHASONE IMPLANT LOCATED IN THE CRYSTALLINE LENS – THE PARTICULARITIES OF THE PHACOEMULSIFICATION SURGERY
Published 2023 - 27th ESCRS Winter Meeting
Reference: P059 | Type: Presented Poster & Poster Submission | DOI: 10.82333/qq5m-mf28
Authors: Rita Teixeira Martins* 1 , Joana Santos Oliveira 1 , Claudia Oliveira Ferreira 1 , Ana Margarida Ferreira 1 , Margarida Ribeiro 1 , Fernando Falcão-Reis 1 , João Paulo Macedo 1
1Centro Hospitalar Universitário São João, Porto,Porto,Portugal
Purpose
Setting
Centro Hospitalar Universitário de São João, Porto, Portugal.
Methods
Results
A sixty-years-old man was followed in our department due to diabetic macular edema and an intravitreal dexamethasone implant (Ozurdex®) was decided to be done in his right eye (RE). The patient missed the appointment fifteen days later. Four months later, he complained of vision loss (from 4/10 to 2/10 RE). In the slit-lamp observation, it was observed the Ozurdex® implant into the crystalline lens. There was no progression of the pre-existing cataract, the intraocular pressure was normal, and no inflammation was identified in anterior segment. Surprisingly, the retinal OCT showed an improvement of the macular edema. Due to decrease visual acuity, the patient was proposed to surgery and a phacoemulsification surgery with three piece intraocular lens implanted in sulcus associated with anterior vitrectomy was done. Hydrodissection and hydrodelineation were not performed to avoid the aggravation of the foreseeable posterior capsular rupture. The reposition of the implant in the vitreous cavity was not successful.
Conclusion